Literature DB >> 17608672

Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis.

Eiichi Ogawa1, Norihiro Furusyo, Kazuhiro Toyoda, Hiroaki Takeoka, Shigeru Otaguro, Maki Hamada, Masayuki Murata, Yasunori Sawayama, Jun Hayashi.   

Abstract

AIM/
METHODS: The aim of the present study was to compare the diagnostic performance of transient elastography (FibroScan) with that of serum fibrosis markers and stages of hepatic fibrosis by biopsy in 68 patients with chronic hepatitis B virus (HBV) and in 161 patients with hepatitis C virus (HCV) infection.
RESULTS: The serum levels of hyaluronic acid (r = 0.601) and type IV collagen (r = 0.663) significantly positively associated with the FibroScan values (all P < 0.05). Classified by fibrosis stages, the median values of FibroScan were 3.5 kPa for F0, 6.4 kPa for F1, 9.5 kPa for F2, 11.4 kPa for F3, and 15.4 kPa forF4 in patients with chronic HBV infection, and were 6.3 kPa for F0, 6.7 kPa for F1, 9.1 kPa for F2, 13.7 kPa for F3, and 26.4 kPa for F4 in those with chronic HCV infection. The values were significantly correlated with fibrosis stage for both (HBV, r = 0.559, P = 0.0093, and HCV, r = 0.686, P < 0.0001).
CONCLUSION: These results suggest that FibroScan is an efficient and simple method for evaluating liver fibrosis in patients with chronic infection, both for HBV and HCV.

Entities:  

Year:  2007        PMID: 17608672     DOI: 10.1111/j.1872-034X.2007.00160.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  25 in total

1.  Measuring fibrosis: is seeing really believing?

Authors:  Tuyet A T Nguyen; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2012-08       Impact factor: 3.199

2.  A new index for non-invasive assessment of liver fibrosis.

Authors:  Naohiro Ichino; Keisuke Osakabe; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shiho Kitahara; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Yuko Arima; Hiroaki Shimazaki; Koji Suzuki; Kentaro Yoshioka
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation.

Authors:  Ki Tae Yoon; Sun Min Lim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Mong Cho; Jun Woo Lee; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

4.  Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients.

Authors:  Hongfang Ding; Ting Wu; Ke Ma; Xiaojing Wang; Zeguang Wu; Wei Guo; Junying Qi; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

5.  Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.

Authors:  Kazuaki Tejima; Ryota Masuzaki; Hitoshi Ikeda; Haruhiko Yoshida; Ryosuke Tateishi; Yosuke Sugioka; Yukio Kume; Tomoko Okano; Tomomi Iwai; Hiroaki Gotoh; Sachiko Katoh; Atsushi Suzuki; Yukako Koike; Yutaka Yatomi; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-03-26       Impact factor: 7.527

6.  Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.

Authors:  Noriyuki Obara; Yoshiyuki Ueno; Koji Fukushima; Yu Nakagome; Eiji Kakazu; Osamu Kimura; Yuta Wakui; Osamu Kido; Masashi Ninomiya; Takayuki Kogure; Jun Inoue; Yasuteru Kondo; Masaaki Shiina; Takao Iwasaki; Takeshi Yamamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

7.  Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis.

Authors:  Myoung Hee Lee; Jae Youn Cheong; Soon Ho Um; Yeon Seok Seo; Dong Joon Kim; Seong Gyu Hwang; Jin Mo Yang; Kwang-Hyub Han; Sung Won Cho
Journal:  Dig Dis Sci       Date:  2010-04-29       Impact factor: 3.199

8.  Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study.

Authors:  Naoko Tsubouchi; Hirofumi Uto; Kotaro Kumagai; Fumisato Sasaki; Shuji Kanmura; Masatsugu Numata; Akihiro Moriuchi; Makoto Oketani; Akio Ido; Katsuhiro Hayashi; Kazunori Kusumoto; Kazuya Shimoda; Sherri O Stuver; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2013-02-18       Impact factor: 4.288

9.  Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated mice.

Authors:  Xi Zhang; Xin-Rong Yang; Yu Chen; Hai-Qing Li; Rui-Min Li; Qing-Xi Yuan; Pei-Ping Zhu; Wan-Xia Huang; Wei-Jun Peng
Journal:  Eur Radiol       Date:  2012-08-19       Impact factor: 5.315

10.  Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment.

Authors:  Eiichi Ogawa; Norihiro Furusyo; Kazuhiro Toyoda; Hiroaki Taniai; Shigeru Otaguro; Mosaburo Kainuma; Masayuki Murata; Yasunori Sawayama; Jun Hayashi
Journal:  BMC Gastroenterol       Date:  2010-04-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.